Concepedia

Cuiman Cai

CC

Statistics

Publications

14

Citations

350

H-Index

13

Active since

1998

Affiliations

Pfizer (United States)(Current)

Gaertner (United States)

NAEJA-RGM Pharmaceuticals (Canada)

Cuiman Cai is an author at Pfizer (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1998–2014

14

Publications

14

Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors

Noel A. Powell, Fred L. Ciske, Cuiman Cai et al. · Bioorganic & Medicinal Chemistry · 2007 · 52 citations · Full text

, , +14

Ketopiperazine-based renin inhibitors: Optimization of the “C” ring

Daniel D. Holsworth, Cuiman Cai, Xue‐Min Cheng et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 37 citations · Full text

, , +12

Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119

Etzer Darout, Ralph P. Robinson, Kim F. McClure et al. · Journal of Medicinal Chemistry · 2012 · 31 citations · Full text

, , +15

The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex

Jeffrey T. Kohrt, Kevin J. Filipski, Wayne L. Cody et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 30 citations · Full text

, , +14

Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors

Daniel D. Holsworth, Mehran Jalaie, Thomas R. Belliotti et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 29 citations · Full text

, , +10

1–5 of 14